Literature DB >> 12547160

Is t(10;11)(p11.2;q23) involving MLL and ABI-1 genes associated with congenital acute monocytic leukemia?

Cristina Morerio1, Cristina Rosanda, Annamaria Rapella, Concetta Micalizzi, Claudio Panarello.   

Abstract

Congenital, or perinatal, leukemias are rarely observed, but retrospective molecular studies seem to suggest a more frequent onset in prenatal life. Myelocytic types are common, and chromosome band 11q23 rearrangements at the MLL locus are characteristic genetic markers. The fusion of the MLL gene with one of its partners, ABI-1, has recently been described in two infant leukemia patients with monocytic involvement and good clinical outcome. We report a case of congenital monocytic leukemia with the same gene involvement and good response to chemotherapy. The blast metaphases were probed by fluorescence in situ hybridization, and t(10;11)(p11.2;q23) involving MLL and ABI-1 genes was demonstrated with the same breakpoint in ABI-1. The congenital presentation of this case suggests a possible relationship of this genetic event with in utero leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12547160     DOI: 10.1016/s0165-4608(02)00616-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

Review 1.  Congenital acute myeloid leukemia with t(8;16) and t(17;19) double translocation: case presentation and literature review.

Authors:  Tae-Jung Sung; Dae-Hyoung Lee; Soon-Ki Kim; Yong-Hoon Jun
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

2.  Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.

Authors:  Meihua Cui; Weidong Yu; Jianqiang Dong; Jie Chen; Xiuru Zhang; Yulan Liu
Journal:  Med Oncol       Date:  2009-06-25       Impact factor: 3.064

3.  Analysis of 59 cases of congenital leukemia reported between 2001 and 2016.

Authors:  Qi Zhang; Zhuxiao Ren; Jie Yang; Aihua Yin
Journal:  J Int Med Res       Date:  2019-09-26       Impact factor: 1.671

4.  ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Rongqiang Liu; Weihao Kong; ZeKun Jiang; Shiyang Zheng; Xiaofeng Yuan; Linsen Ye
Journal:  J Oncol       Date:  2021-08-26       Impact factor: 4.375

5.  Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Adnan Ikhtiar; Thomas Liehr
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.